Christopher H Van Dyck, MD

Christopher H Van Dyck, MD
Psychiatry, Geriatric Psychiatry, Memory and Cognitive Disorders, Neuroimaging
Accepting new patients? Yes
Referrals required? From patients or physicians
Patient type treated: Geriatrics

Christopher H. van Dyck, MD, is Professor of Psychiatry, Neurology, and Neuroscience, Director, Division of Aging and Geriatric Psychiatry; Director of the Alzheimer's Disease Research Unit; Director, Yale Alzheimer's Disease Research Center

His research interests include therapeutic, neuroimaging and genetic studies of Alzheimer's disease (AD) and healthy cognitive aging. Dr. van Dyck is very active in AD therapeutic research. Since 1992 he has participated in 80+ multicenter clinical trials for AD and MCI and has authored several of the trial publications. He serves on the Steering Committees of the NIA Alzheimer's Disease Cooperative Study (ADCS) and Alzheimer's Disease Neuroimaging Initiative (ADNI). Dr. van Dyck’s other significant scholarly contributions include dopamine transporter imaging in healthy aging and the apolipoprotein E e4 Phenotype of AD. In 2005 he received the "Compassion and Cure" Award from the Alzheimer's Association.

  • Professor of Psychiatry, Neurology, and Neuroscience
  • Director, Alzheimer's Disease Research Unit
  • Director, Yale Alzheimer's Disease Research Center
  • Director, Division of Aging and Geriatric Psychiatry

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.